Axsome Therapeutics Inc (AXSM)
87.15
-1.69
(-1.90%)
USD |
NASDAQ |
Nov 04, 16:00
87.16
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Gross Profit Margin (Quarterly): 90.76% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 90.76% |
| March 31, 2024 | 91.60% |
| December 31, 2023 | 89.69% |
| September 30, 2023 | 88.70% |
| June 30, 2023 | 90.15% |
| Date | Value |
|---|---|
| March 31, 2023 | 92.01% |
| December 31, 2022 | 90.60% |
| September 30, 2022 | 88.58% |
| June 30, 2022 | 88.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.58%
Minimum
Sep 2022
92.01%
Maximum
Mar 2023
90.10%
Average
90.15%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Krystal Biotech Inc | 91.45% |
| Pfizer Inc | 70.27% |
| Sarepta Therapeutics Inc | 87.73% |
| Moderna Inc | 47.96% |
| NovaBay Pharmaceuticals Inc | 66.33% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -156.4% |
| Return on Assets | -53.30% |
| Return on Invested Capital | -82.21% |
| Profit Margin (Quarterly) | -91.03% |
| Operating Margin (Quarterly) | -87.06% |
| Return on Net Operating Assets | -172.9% |